These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


60 related items for PubMed ID: 21565353

  • 41. A peptide fusion a day keeps the aggregates away.
    Prochiantz A.
    Mol Ther; 2007 Feb; 15(2):226-7. PubMed ID: 17235297
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Peptide-Based HIV Entry Inhibitors.
    Pu J, Wang Q, Jiang S.
    Adv Exp Med Biol; 2022 Feb; 1366():15-26. PubMed ID: 35412132
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. GBV-C: state of the art and future prospects.
    Giret MT, Kallas EG.
    Curr HIV/AIDS Rep; 2012 Mar; 9(1):26-33. PubMed ID: 22246585
    [Abstract] [Full Text] [Related]

  • 47. Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C.
    Sánchez-Martín MJ, Hristova K, Pujol M, Gómara MJ, Haro I, Alsina MA, Busquets MA.
    J Colloid Interface Sci; 2011 Aug 01; 360(1):124-31. PubMed ID: 21565353
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C.
    Sánchez-Martín MJ, Hristova K, Pujol M, Gómara MJ, Haro I, Alsina MA, Busquets MA.
    J Colloid Interface Sci; 2011 Aug 01; 360(1):124-31. PubMed ID: 21565353
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.
    Herrera E, Gomara MJ, Mazzini S, Ragg E, Haro I.
    J Phys Chem B; 2009 May 21; 113(20):7383-91. PubMed ID: 19402654
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C.
    Sánchez-Martín MJ, Hristova K, Pujol M, Gómara MJ, Haro I, Alsina MA, Busquets MA.
    J Colloid Interface Sci; 2011 Aug 01; 360(1):124-31. PubMed ID: 21565353
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C.
    Sánchez-Martín MJ, Hristova K, Pujol M, Gómara MJ, Haro I, Alsina MA, Busquets MA.
    J Colloid Interface Sci; 2011 Aug 01; 360(1):124-31. PubMed ID: 21565353
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [New Search]
    of 3.